Apyx Medical Corporation (APYX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 12.49M | 19.16M | 12.88M | 11.37M | 9.43M | 14.22M | 11.49M | 12.15M | 10.24M | 14.66M | 11.98M | 13.57M |
| Revenue Growth % | 32.45% | 34.75% | 12.1% | -6.39% | -7.95% | -3% | -4.08% | -10.46% | -15.63% | 16.26% | 31.4% | 31.84% |
| Cost of Goods Sold | 7.82M | 21.18M | 4.58M | 4.29M | 3.77M | 5.26M | 4.53M | 9.34M | 4.29M | 10.6M | 4M | 4.29M |
| COGS % of Revenue | 62.59% | 110.5% | 35.57% | 37.72% | 39.93% | 36.97% | 39.46% | 76.86% | 41.93% | 72.3% | 33.38% | 31.62% |
| Gross Profit | 4.67M | -2.01M | 8.3M | 7.08M | 5.67M | 8.96M | 6.95M | 2.81M | 5.95M | 4.06M | 7.98M | 9.28M |
| Gross Margin % | 37.41% | -10.5% | 64.43% | 62.28% | 60.07% | 63.03% | 60.54% | 23.14% | 58.07% | 27.7% | 66.62% | 68.38% |
| Gross Profit Growth % | -17.53% | -122.45% | 19.31% | 151.97% | -4.77% | 120.68% | -12.84% | -69.71% | -21.44% | -50.71% | 38.58% | 34.21% |
| Operating Expenses | 5.58M | -2.02M | 9.13M | 9.66M | 8.72M | 12.01M | 10.59M | 8.36M | 12.56M | 9.84M | 12.62M | 10.51M |
| OpEx % of Revenue | 44.7% | -10.56% | 70.89% | 84.91% | 92.43% | 84.46% | 92.18% | 68.8% | 122.65% | 67.1% | 105.34% | 77.49% |
| Selling, General & Admin | 3.58M | 11.04M | 8.33M | 8.83M | 7.91M | 10.89M | 9.45M | 6.93M | 11.17M | 8.59M | 11.21M | 11.85M |
| SG&A % of Revenue | 28.63% | 57.63% | 64.67% | 77.67% | 83.9% | 76.61% | 82.24% | 57.07% | 109.01% | 58.59% | 93.57% | 87.32% |
| Research & Development | 765K | 944K | 801K | 824K | 804K | 1.12M | 1.14M | 1.42M | 1.4M | 1.25M | 1.41M | 1.36M |
| R&D % of Revenue | 6.12% | 4.93% | 6.22% | 7.25% | 8.53% | 7.85% | 9.94% | 11.72% | 13.64% | 8.51% | 11.77% | 10% |
| Other Operating Expenses | 1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K |
| Operating Income | -911K | 11K | -832K | -2.57M | -3.05M | -3.05M | -3.63M | -5.55M | -6.62M | -5.78M | -4.64M | -1.24M |
| Operating Margin % | -7.29% | 0.06% | -6.46% | -22.63% | -32.35% | -21.43% | -31.64% | -45.66% | -64.57% | -39.39% | -38.72% | -9.1% |
| Operating Income Growth % | 70.14% | 100.36% | 77.11% | 53.6% | 53.88% | 47.23% | 21.61% | -349.15% | -17.89% | 2.65% | 19.8% | 79.33% |
| EBITDA | -709K | 232K | -700K | -2.44M | -2.91M | -2.91M | -3.49M | -5.39M | -6.46M | -5.62M | -4.45M | -1.08M |
| EBITDA Margin % | -5.68% | 1.21% | -5.44% | -21.47% | -30.89% | -20.43% | -30.39% | -44.37% | -63.04% | -38.36% | -37.17% | -7.99% |
| EBITDA Growth % | 75.66% | 107.98% | 79.95% | 54.7% | 54.89% | 48.33% | 21.57% | -397.32% | -19.42% | 1.87% | 20.03% | 81.08% |
| D&A (Non-Cash Add-back) | 202K | 221K | 132K | 132K | 138K | 142K | 144K | 156K | 157K | 152K | 186K | 151K |
| EBIT | -911K | 11K | -464K | -2.3M | -2.75M | -2.92M | -3.23M | -5.11M | -6.14M | -8.42M | -4.41M | -410K |
| Net Interest Income | -1.13M | -1.17M | -1.12M | -1.11M | -1.07M | -1.36M | -1.05M | -988K | -901K | -673K | -337K | -364K |
| Interest Income | 244K | 234K | 292K | 278K | 304K | 294K | 378K | 439K | 495K | 443K | 248K | 179K |
| Interest Expense | 1.37M | 1.41M | 1.41M | 1.39M | 1.38M | 1.65M | 1.43M | 1.43M | 1.4M | 1.12M | 585K | 543K |
| Other Income/Expense | -1.09M | -1.16M | -1.04M | -1.11M | -1.07M | -1.52M | -1.03M | -989K | -922K | -3.76M | -356K | 282K |
| Pretax Income | -2M | -1.15M | -1.88M | -3.69M | -4.12M | -4.57M | -4.66M | -6.54M | -7.54M | -9.54M | -4.99M | -953K |
| Pretax Margin % | -16.01% | -5.98% | -14.58% | -32.44% | -43.72% | -32.13% | -40.6% | -53.8% | -73.57% | -65.05% | -41.69% | -7.02% |
| Income Tax | 143K | 94K | 78K | 49K | 49K | 89K | 60K | 50K | 53K | 87K | -318K | 66K |
| Effective Tax Rate % | -7.15% | -8.2% | -4.16% | -1.33% | -1.19% | -1.95% | -1.29% | -0.76% | -0.7% | -0.91% | 6.37% | -6.93% |
| Net Income | -2.11M | -1.3M | -1.98M | -3.78M | -4.15M | -4.63M | -4.7M | -6.56M | -7.58M | -9.61M | -4.63M | -994K |
| Net Margin % | -16.88% | -6.78% | -15.41% | -33.22% | -44.01% | -32.54% | -40.94% | -53.96% | -73.96% | -65.52% | -38.65% | -7.33% |
| Net Income Growth % | 49.2% | 71.93% | 57.81% | 42.37% | 45.22% | 51.83% | -1.6% | -559.56% | -117.51% | -58.82% | 19.69% | 81.68% |
| Net Income (Continuing) | -2.14M | -1.24M | -1.96M | -3.74M | -4.17M | -4.66M | -4.72M | -6.59M | -7.59M | -9.62M | -4.67M | -1.02M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 256K | 291K | 232K | 203K | 133K | 125K | 156K | 177K | 207K | 221K | 238K | 137K |
| EPS (Diluted) | -0.05 | -0.03 | -0.05 | -0.09 | -0.12 | -0.12 | -0.14 | -0.19 | -0.22 | -0.28 | -0.13 | -0.03 |
| EPS Growth % | 58.33% | 74.33% | 65% | 51.16% | 45.45% | 57.14% | -7.69% | -562.02% | -120% | -64.71% | 23.53% | 82.06% |
| EPS (Basic) | -0.05 | -0.03 | -0.05 | -0.09 | -0.12 | -0.12 | -0.14 | -0.19 | -0.22 | -0.28 | -0.13 | -0.03 |
| Diluted Shares Outstanding | 42.16M | 42.16M | 40.73M | 40.73M | 35.54M | 38.22M | 34.64M | 34.64M | 34.64M | 34.64M | 34.64M | 34.6M |
| Basic Shares Outstanding | 42.16M | 42.16M | 40.73M | 40.73M | 35.54M | 38.22M | 34.64M | 34.64M | 34.64M | 34.64M | 34.64M | 34.6M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |